GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
319 filings
306 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2021-06-14 | — | |
| 6-K | 2021-06-22 | — | |
| 6-K | 2021-06-23 | — | |
| 6-K | 2021-06-24 | — | |
| 6-K | 2021-06-25 | — | |
| 6-K | 2021-07-01 | — | |
| 6-K | 2021-07-02 | — | |
| 6-K | 2021-07-09 | — | |
| 6-K | 2021-07-12 | — | |
| 6-K | 2021-07-12 | 2021-12-07 | |
| 6-K | 2021-07-13 | — | |
| 6-K | 2021-07-14 | — | |
| 6-K | 2021-07-15 | — | |
| 6-K | 2021-07-16 | — | |
| 6-K | 2021-07-22 | — | |
| 6-K | 2021-07-23 | — | |
| 6-K | 2021-07-26 | — | |
| 6-K | 2021-07-28 | — | |
| 6-K | 2021-08-02 | — | |
| 6-K | 2021-08-05 | — | |
| 6-K | 2021-08-11 | — | |
| 6-K | 2021-08-23 | — | |
| 6-K | 2021-08-25 | — | |
| 6-K | 2021-08-31 | — | |
| 6-K | 2021-09-01 | — | |
| 6-K | 2021-09-03 | — | |
| 6-K | 2021-09-07 | — | |
| 6-K | 2021-09-09 | — | |
| 6-K | 2021-09-13 | — | |
| 6-K | 2021-09-20 | — | |
| 6-K | 2021-09-22 | — | |
| 6-K | 2021-09-24 | — | |
| 6-K | 2021-10-01 | — | |
| 6-K | 2021-10-12 | — | |
| 6-K | 2021-10-13 | — | |
| 6-K | 2021-10-14 | — | |
| 6-K | 2021-10-15 | — | |
| 6-K | 2021-10-27 | — | |
| 6-K | 2021-11-01 | — | |
| 6-K | 2021-11-05 | — | |
| 6-K | 2021-11-10 | — | |
| 6-K | 2021-11-12 | — | |
| 6-K | 2021-11-15 | — | |
| 6-K | 2021-11-17 | — | |
| 6-K | 2021-11-23 | — | |
| 6-K | 2021-11-24 | — | |
| 6-K | 2021-12-01 | — | |
| 6-K | 2021-12-02 | — | |
| 6-K | 2021-12-07 | — | |
| 6-K | 2021-12-13 | — |
Showing 151–200 of 835 filings